IN2013MU01252A - - Google Patents

Info

Publication number
IN2013MU01252A
IN2013MU01252A IN1252MU2013A IN2013MU01252A IN 2013MU01252 A IN2013MU01252 A IN 2013MU01252A IN 1252MU2013 A IN1252MU2013 A IN 1252MU2013A IN 2013MU01252 A IN2013MU01252 A IN 2013MU01252A
Authority
IN
India
Prior art keywords
composition
dexmethylphenidate
salts
relates
pharmaceutical composition
Prior art date
Application number
Inventor
Girish Kumar Jain
Rahul Sudhakar Dabre
Jitendrakumar Chordiya
Inderjeetsingh Huda
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/060083 priority Critical patent/WO2014174387A1/en
Priority to US14/766,977 priority patent/US20150366850A1/en
Priority to BR112015020261A priority patent/BR112015020261A2/en
Priority to CN201480011294.6A priority patent/CN105025883A/en
Priority to RU2015146324A priority patent/RU2015146324A/en
Priority to EP14718755.3A priority patent/EP2994112A1/en
Priority to IN1252MU2013 priority patent/IN2013MU01252A/en
Publication of IN2013MU01252A publication Critical patent/IN2013MU01252A/en

Links

Abstract

The present invention relates to a modified release pharmaceutical composition of dexmethylphenidate or salts thereof. In particular, the present invention relates to a modified release pharmaceutical composition comprising plurality of components exhibiting both immediate and extended release of dexmethylphenidate or salts thereof. The composition may provide therapeutically effective plasma concentration over a period of 24 hours to treat attention deficit hyperactivity disorder when administered to a patient in need thereof. The invention also includes process of preparing such composition.
IN1252MU2013 2013-03-29 2014-03-24 IN2013MU01252A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PCT/IB2014/060083 WO2014174387A1 (en) 2013-03-29 2014-03-24 Modified release pharmaceutical compositions of dexmethylphenidate or salts thereof
US14/766,977 US20150366850A1 (en) 2013-03-29 2014-03-24 Modified release pharmaceutical compositions of dexmethylphenidate or salts thereof
BR112015020261A BR112015020261A2 (en) 2013-03-29 2014-03-24 pharmaceutical compositions of dexmethylphenidate or modified release salts thereof
CN201480011294.6A CN105025883A (en) 2013-03-29 2014-03-24 Modified release pharmaceutical compositions of dexmethylphenidate or salts thereof
RU2015146324A RU2015146324A (en) 2013-03-29 2014-03-24 PHARMACEUTICAL COMPOSITIONS OF MODIFIED RELEASE OF DEXMETHYLPHENIDATE OR ITS SALTS
EP14718755.3A EP2994112A1 (en) 2013-03-29 2014-03-24 Modified release pharmaceutical compositions of dexmethylphenidate or salts thereof
IN1252MU2013 IN2013MU01252A (en) 2013-03-29 2014-03-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1252MU2013 IN2013MU01252A (en) 2013-03-29 2014-03-24

Publications (1)

Publication Number Publication Date
IN2013MU01252A true IN2013MU01252A (en) 2015-04-17

Family

ID=54395653

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1252MU2013 IN2013MU01252A (en) 2013-03-29 2014-03-24

Country Status (1)

Country Link
IN (1) IN2013MU01252A (en)

Similar Documents

Publication Publication Date Title
MX2020010535A (en) Methods of treating cancer.
PH12015500825B1 (en) Substituted benzene compounds
IN2015DN01156A (en)
MX365939B (en) Nuclear transport modulators and uses thereof.
MX2015006234A (en) Use of akkermansia for treating metabolic disorders.
MX344530B (en) Substituted benzene compounds.
MX368833B (en) Quinoline and quinazoline amides as modulators of sodium channels.
MX2013011908A (en) Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors.
IN2015DN03219A (en)
PH12014501991B1 (en) Phenicol antibacterials
MX356755B (en) Fumigillol type compounds and methods of making and using same.
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MX2015005733A (en) Tricyclic compounds for use in the treatment and/or control of obesity.
MX364528B (en) Withanolides useful for the treatment of neurodegenerative diseases.
IN2015DN02109A (en)
GB201115977D0 (en) Neurodevelopmental disorders
IN2013MU01252A (en)
IN2013MU01251A (en)
IN2013MU01243A (en)
IN2013MU01239A (en)
IN2013MU01245A (en)
IN2013MU01250A (en)
IN2013MU01244A (en)
IN2013MU01246A (en)